The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

O.V. Kotova

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

E.V. Tsareva

Peoples’ Friendship University of Russia;
Sleep Service Unison

V.E. Medvedev

Peoples Friendship University of Russian

A.A. Belyaev

Sklifosovsky Scientific Research Institute of Emergency Medical Care

E.V. Gushanskaya

Peoples Friendship University of Russian

V.I. Frolova

RUDN University

I.G. Kotelnikova

Moscow Endocrine Plant

Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome

Authors:

O.V. Kotova, E.V. Tsareva, V.E. Medvedev, A.A. Belyaev, E.V. Gushanskaya, V.I. Frolova, I.G. Kotelnikova

More about the authors

Views: 1370

Downloaded: 7


To cite this article:

Kotova OV, Tsareva EV, Medvedev VE, Belyaev AA, Gushanskaya EV, Frolova VI, Kotelnikova IG. Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(12):39‑44. (In Russ.)
https://doi.org/10.17116/jnevro202212212139

Recommended articles:
Inso­mnia in neurological patients with disa­bilities. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(2):12-20
Clinico-psychological profile and life quality of patients with post-COVID syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(4):53-58

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.